Novel Approaches to Early and Preclinical Parkinson's Disease
Wednesday, July 8, 2009 1:00 PM - 2:00 PM ET

Description and Intended Audience:

This segment features Dr. Matthew Stern focusing on Early Diagnosis and Treatment of Parkinson's Disease. This activity is intended for neurologists, pharmacists, and other medical professionals with a specific interest in the management of Parkinson's disease.

Learning Objectives:

Upon completion of this Teleconference, participants should be able to:

  • Discuss the issues involved in choosing therapy for early Parkinson's Disease
  • Identify approaches to the pre clinical detection of Parkinson's Disease
Speaker Information and Disclosures:
Robert Hauser, MD

Matthew Stern, MD
The University of Pennsylvania
Parker Family Professor of Neurology
Philadelphia, PA

Matthew B. Stern, MD, is the Director of the Parkinson’s Disease and Movement Disorders Center and is the Parker Family Professor of Neurology at the University of Pennsylvania, Philadelphia. Dr Stern also codirects the Parkinson’s Disease Research, Education, and Clinical Center at the Philadelphia Veteran’s Hospital. Dr Stern received his medical degree from Duke University, Durham, North Carolina, and completed his neurology training at the University of Pennsylvania.

The Center at Penn is one of the largest of its type in the country and has a long track record of achievement in clinical trials and experimental therapeutics. Dr Stern has authored or co-authored numerous papers on Parkinson’s disease (PD) and edited or co-edited 8 books. He has served on the executive committee of the American Academy of Neurology’s Movement Disorders Section and is a member of the American Neurological Association. He has held several leadership positions in the international Movement Disorder Society and is currently Secretary-elect.

In addition to serving as institutional investigator for numerous clinical trials, Dr Stern has been the principal investigator or co-principal investigator of many studies related to PD. He serves on numerous consulting boards and has lectured throughout the world on PD and related disorders.

Disclosure: Consultant – Boehringer-Ingelheim, Novartis, Teva, Ipsen, NuPathe, Schering Plough.

CE Information:

Physicians:

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cine-Med and Astute Technology. Cine-Med is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Cine-Med, Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists:

Cine-Med is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is accredited for 0.1 CEU (1.0 contact hour) of continuing education credit. ACPE Universal Number 0399-999-09-014-H01-P. Activity type: knowledge-based.

How to get CE credit:

To receive credit, participants must view the webcast, register on this site, and successfully complete the post-test and evaluation (successful passing grade >=70%). Certificates can be printed on line.